For the Inventor, By the Inventor

Enter inventor name

Chapel Hill, NC, United States of America

Richard C Boucher

USPTO Granted Patents = 52 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 2.3

ph-index = 26

Forward Citations = 1,441(Granted Patents)

Forward Citations (Not Self Cited) = 1,227(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

27 out of 1,271

The University of North Carolina at Chapel Hill

Parion Sciences, Inc.

Molichem Medicines, Inc.

Inspire Pharmaceuticals, Inc.

5. 3 out of 872

University of Missouri

6. 1 out of 444

Research, Incorporated

7. 1 out of 521

Burroughs Wellcome Co.

8. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2020

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Sodium Channel Blockers

Dendrimer Compounds

Inhaled Hypertonic Saline

Aerosol Delivery Systems

Chronic Obstructive Pulmonary Disease

Cystic Fibrosis

Mucosal Hydration

Airway Drug Delivery

Uridine Triphosphate

Dinucleotides

Taste Modulators

P2U Receptor

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10526292 - Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases (2020-01-07),

2. 10335558 - Methods of treatment (2019-07-02),

3. 9987443 - Inhaled hypertonic saline delivered by a heated nasal cannula (2018-06-05),

4. 9878988 - Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases (2018-01-30),

5. 9849129 - Sodium channel blockers for skin disorders (2017-12-26),

6. 9408988 - Inhaled hypertonic saline delivered by a heated nasal cannula (2016-08-09),

7. 9260398 - Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases (2016-02-16),

8. 8980898 - Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases (2015-03-17),

9. 8952214 - Animal model for chronic obstructive pulmonary disease and cystic fibrosis (2015-02-10),

10. 8945605 - Aerosol delivery systems, compositions and methods (2015-02-03),

11. 8778383 - Methods of treatment (2014-07-15),

12. 8551534 - Inhaled hypertonic saline delivered by a heated nasal cannula (2013-10-08),

13. 8288391 - Pyrazinoylguanidine compounds for use as taste modulators (2012-10-16),

14. 8163758 - Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity (2012-04-24),

15. 8058278 - Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes (2011-11-15),

Title: The Innovative Journey of Richard C. Boucher

Introduction: Richard C. Boucher, a pioneering inventor based in Chapel Hill, NC, has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Richard C. Boucher's most recent patents include inventions in the healthcare technology sector, focusing on advancements in medical devices and diagnostic tools.

Career Highlights: With a career spanning over two decades, Richard C. Boucher has established himself as a leading figure in the world of inventions. His work has led to numerous patents that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Richard C. Boucher has collaborated with top research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his innovative ideas into tangible products that benefit society.

Conclusion: Richard C. Boucher's dedication to innovation and his passion for creating impactful inventions have solidified his reputation as a trailblazer in the world of patents. His work continues to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…